Article 1 is about vaccines. The table I see that has Pfizer listed is a table of vaccines. The candidate they are listed next to is an RNA vaccine. The name of the vaccine candidate platform is listed as Moderna/NAIAD.

Reviewing your original post, you acknowledge the table in question is a vaccine candidate table.

Apabetalone, as is readily apparent, is not a vaccine. It is a potential therapeutic treatment. It seems obvious to me that Pfizer would have its efforts focused on both potential vaccines (which is what your article is about) and potential therapies. We still do not have the name of Pfizer's potential therapy, though it could be called "Apabetalone".

Unless something above is incorrect, or I am missing something, the article about vaccines is irrelevant.

That said, the following article is discouraging, because it says Pfizer is testing a "lead anti-viral," which Apabetalone is not:

https://www.biospace.com/article/pfizer-and-biontech-accelerate-collaboration-on-covid-19-vaccine-pfizer-picks-drug-to-test/